Skip to main content
. 2022 Oct 4;26(6):440–453. doi: 10.52547/ibj.3716

Table 2.

Clinicopathological parameters of the study population and expression profiles of INPP5A, HLA-G1, IL-10, and MMP-21

Parameters No. INPP5A expression HLA-G1 expression MMP-21 expression IL-10 expression
-/ -/ -/ -/ -/ -/ -/ -/
Gender
Male 32 30 2 24 8 13 19 15 17
Female 24 21 3 19 5 9 15 8 13
Grade of differentiation
P.D. 10 7 3 8 2 5 5 2 6
M.D. 34 33 1 25 9 13 21 15 19
W.D. 12 11 1 10 2 4 8 7 5
Tumor location
Lower 23 20 3 21 2 10 13 10 13
Middle 32 31 1 21 11 12 20 15 17
Upper 1 0 1 1 0 0 1 1 0
Depth of tumor invasion
T1 3 1 2 3 0 1 2 1 2
T2 8 8 0 5 3 2 6 5 3
T3 45 42 3 35 10 19 26 20 25
LNM
No metastasis 31 27 4 23 8 12 19 11 20
Node metastasis 25 24 1 20 5 10 15 15 10
Stage of tumor progression
I 1 1 0 1 0 1 0 0 1
IIa 29 26 3 21 8 11 18 11 18
IIb 5 3 2 3 2 0 5 3 2
III 21 21 0 18 3 10 11 12 9
IV 0 0 0 0 0 0 0 0 0

P.D., poorly differentiated; M.D., moderately differentiated; W.D., well differentiated; , overexpression; , underexpression ; -, normal